Early Access — free while we kick the tires
EdgarHawk

Imran Talat

Chief Executive Officer

Director Officer
1 filing analyzed · 1 company · Latest 2024-12-10

Companies

Company Buys Sells Direction
Rani Therapeutics Holdings, Inc. RANI 1 0 Net buying

Activity

December 2024
Buy
10,296 shares
$19,974
Significance 7/10

CEO Imran Talat bought 10,296 shares of RANI at $1.94 on 2024-12-09; stock down 75.8% from 52-week high, company unprofitable with -$6.8M net income.

Imran Talat, as CEO, purchased 10,296 shares at $1.94 on 2024-12-09, bringing his post-transaction holdings to 494.8K shares. This open-market buy comes as RANI trades at $1.90 current price, down 75.8% from its 52-week high of $7.85, and the stock has declined 21.2% over the past 30 days and 22.8% over 90 days. The company's fundamentals are severely stressed: revenue is $0.00 in the latest quarter, with a net loss of $-6.8M annually and negative 100.0% annual revenue growth. Notably, Imran Talat's prior 5 buys at RANI (all conducted in November and December 2023) demonstrated strong 90-day timing outcomes, with average 90d returns of +62.4%, though those purchases occurred 12+ months ago when valuations were materially higher. The extreme price deterioration since those prior trades and the company's cash-consumption profile without revenue generation represent a fundamentally different risk environment than his prior purchase windows at this ticker.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access